NOVAREX Co.,Ltd. (KOSDAQ:194700)
South Korea · Delayed Price · Currency is KRW 12,870
-600 (-4.45%)
At close: Jul 20, 2026
NOVAREX Market Cap
NOVAREX has a market cap or net worth of 221.39 billion as of July 20, 2026. Its market cap has decreased by -41.69% in one year.
Market Cap
221.39B
Enterprise Value
209.14B
Revenue
404.26B
Ranking
n/a
PE Ratio
6.43
Stock Price
12,870.00
ChartMarket Cap Chart
Since November 14, 2018, NOVAREX's market cap has increased from 180.98B to 221.39B, an increase of 22.33%. That is a compound annual growth rate of 2.66%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 221.39B | -10.67% |
| Dec 30, 2025 | 247.83B | 86.67% |
| Dec 30, 2024 | 132.77B | -38.22% |
| Dec 28, 2023 | 214.90B | 19.61% |
| Dec 29, 2022 | 179.68B | -41.23% |
| Dec 30, 2021 | 305.72B | -1.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| HEM Pharma | 282.02B |
| ImmuneOncia Therapeutics | 257.84B |
| DAE HWA Pharmaceutical | 162.90B |
| Cosmax Nbt | 162.79B |
| CellBion | 158.09B |
| Vivozon Pharmaceutical | 143.49B |
| GC WellBeing | 139.16B |
| Kyung Dong Pharmaceutical | 132.96B |